特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949646

市販薬(OTC薬)市場:2019年~2025年

Over the Counter (OTC) Drugs Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
市販薬(OTC薬)市場:2019年~2025年
出版日: 2020年06月23日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の市販薬(OTC薬)市場は、予測期間中に大幅に成長する予定です。OTC薬は、医師による処方箋や監督なしで、2つの当事者間で直接購入されるものです。 OTC薬は臨床試験を必要としません。市場の成長に貢献する要因には、世界中のOTC薬の手頃な価格があります。さらに、オンライン流通チャネルでOTC薬が入手できることが、市場の将来的な成長の機会を生み出すとみられています。 インターネットの普及と相まって、eコマース業界の成長により、オンライン流通チャネルは予測期間中にかなりの速度で成長すると推定されています。

地理的には、アジア太平洋地域が予測期間中に同市場で大きな成長率を示すと推定されています。この地域での老齢人口の増加が、市場の成長を牽引しています。さらに、 ヘルスケアインフラの改善は、市場の地域的な成長をさらに後押しします。

当レポートでは、世界の市販薬(OTC薬)市場について調査し、市場の概要とともに、製品タイプ別、流通チャネル別、地域別の動向、競合動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
  • 規則と規制

第3章 競合情勢

  • 会社シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Bayer AG
    • GlaxoSmithKline Plc
    • Novartis International AG
    • Pfizer, Inc
    • Sanofi SA

第4章 市場決定要因

動機

抑制要因

  • 機会

第5章 市場セグメンテーション

  • 製品タイプ別市場
    • 鎮痛剤と鎮痛剤
    • 咳、風邪、インフルエンザ治療薬
    • ビタミンとミネラルサプリメント
    • 眼科製品
    • その他
  • 流通チャネル別市場
    • 小売およびスーパーマーケット
    • オンラインプラットフォーム

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Achelios therapeutics., Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Amway Corp.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis International AG
  • Perrigo Co. plc
  • Pfizer, Inc
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL ANALGESICS AND PAIN RELIEVERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL COUGH, COLD AND FLU PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL DERMATOLOGICAL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL GASTROINTESTINAL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL OPHTHALMIC PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 10. GLOBAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL VITAMIN AND HEALTH FOOD STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICA OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 15. NORTH AMERICAN OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 16. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 18. EUROPE OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 21. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 23. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2018 VS 2025 (%)
  • 3. GLOBAL OVER THE COUNTER (OTC) DRUG MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD OVER THE COUNTER (OTC) DRUG MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2021965

Global Over the Counter (OTC) Drugs Market Size, Share & Trends Analysis Report By Product Type (Analgesics & Pain Relievers; Cough, Cold & Flu Products; Vitamin & Mineral Supplements; Ophthalmic Products; and Others), By Distribution Channel (Retail & Supermarkets and Online Platform), and Forecast 2019-2025

The global Over the Counter (OTC) drugs market is anticipated to grow significantly during the forecast period. Over the Counter drugs are purchased directly between two parties, without the supervision of an exchange or prescription by physician. OTC drugs don't require any clinical trials. The factor contributing to the growth of the market includes the affordable price of OTC drugs across the globe. Further, the availability of OTC drugs on online distribution channel tends to create an opportunity for the future growth of the market.

The global Over the counter (OTC) drugs market is segmented based on product type and distribution channel. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health. Based on the distribution channel, the market is bifurcated into retail & supermarkets and online platform. Online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration.

Geographically, the study of the global over the counter (OTC) drugs market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global over the counter (OTC) drugs market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Moreover, the study of the global over the counter (OTC) drugs market report covers the analysis of various players operating in the market. Some of the key players covered in the report include Bayer AG, GlaxoSmithKline Plc, Novartis International AG, Merck KGaA, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and others.

Research Methodology

The market study of the global OTC drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the government organizations, pharmaceuticals companies, pharmacies and other related industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Over the Counter (OTC) drugs Market Research and Analysis by Product Type

The Report Covers:

  • Comprehensive research methodology of the global OTC drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global OTC drugs market.
  • Insights about market determinants which are stimulating the global OTC drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Bayer AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. GlaxoSmithKline Plc
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Novartis International AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Pfizer, Inc
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Sanofi SA
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
    • 4.1. Opportunities

5. Market Segmentation

  • 5.1. Over the Counter (OTC) drug Market by Product Type
    • 5.1.1. Analgesics and Pain Relievers
    • 5.1.2. Cough, Cold and Flu Products
    • 5.1.3. Vitamin & Mineral Supplements
    • 5.1.4. Ophthalmic Products
    • 5.1.5. Others
  • 5.2. Over the Counter (OTC) drug Market by Distribution Channel
    • 5.2.1. Retail & Supermarket
    • 5.2.2. Online Platform

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Achelios therapeutics., Inc.
  • 7.2. Alkem Laboratories Ltd.
  • 7.3. Amgen Inc.
  • 7.4. Amway Corp.
  • 7.5. AstraZeneca PLC
  • 7.6. Bayer AG
  • 7.7. Boehringer Ingelheim International GmbH
  • 7.8. Bristol-Myers Squibb Co.
  • 7.9. Cipla Ltd.
  • 7.10. Dr. Reddy's Laboratories Ltd.
  • 7.11. GlaxoSmithKline Plc
  • 7.12. Glenmark Pharmaceuticals Ltd
  • 7.13. Johnson & Johnson Services, Inc.
  • 7.14. Merck KGaA
  • 7.15. Novartis International AG
  • 7.16. Perrigo Co. plc
  • 7.17. Pfizer, Inc
  • 7.18. Reckitt Benckiser Group plc
  • 7.19. Sanofi SA
  • 7.20. Sun Pharmaceutical Industries Ltd.
  • 7.21. Teva Pharmaceutical Industries Ltd.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.